News Sentiment

AVNS sentiment intelligence

Avanos Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 70 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 24.93 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 70

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+0.0% over one week, -0.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

Avanos to supplement proxy after shareholder suits; J.P. Morgan valuation range cited

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend active -0.1% over four weeks
Fair value 41.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 55
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 70
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 19
TradingView 8
AD HOC NEWS 4
PR Newswire 3
TradingKey 3
Quartr 2
Stock Titan 2
StockStory 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 26
Deals and strategy 12
Macro sensitivity 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 70
TradingView Direct company coverage

Avanos to supplement proxy after shareholder suits; J.P. Morgan valuation range cited

Avanos will voluntarily supplement its definitive proxy statement due to shareholder lawsuits alleging disclosure deficiencies related to its pending $25.00-per-share merger. The company denies the allegations, stating the supplement aims to avoid litigation delays and costs, wit

Tone
Negative 38/100
Event
Deals and strategy
Published
15 Jul 2026 09:47
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Avanos Medical, Inc. – MUN:8HH

This article displays the "Price to earnings forward" metric for Avanos Medical, Inc. (MUN:8HH) on the TradingView platform. The content primarily shows navigation and interface elements of the TradingView site, with the specific financial data point itself being "Period Value Ch

Tone
Neutral 50/100
Event
Earnings
Published
10 Jul 2026 06:09
Source
TradingView
Latham & Watkins LLP Direct company coverage

Latham Advises on Financing for American Industrial Partners’ US$1.272 Billion Acquisition of Avanos Medical, Inc.

Latham & Watkins LLP represented the financing sources for American Industrial Partners' (AIP) acquisition of Avanos Medical, Inc., a medical technology company. AIP acquired Avanos in an all-cash transaction valued at approximately US$1.272 billion. The Latham team involved part

Tone
Positive 70/100
Event
Deals and strategy
Published
09 Jul 2026 00:10
Source
Latham & Watkins LLP
Simply Wall Street Direct company coverage

Has Avanos Medical (AVNS) Run Ahead Of Fundamentals On Its Russell Index Removal?

Avanos Medical (AVNS) was recently removed from the Russell 2000 Defensive and Value-Defensive Indexes, which can impact institutional trading. Despite this, AVNS has seen significant recent share price gains of 79.02% over 90 days and 122.90% year-to-date. The article questions

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 00:10
Source
Simply Wall Street
Quartr Direct company coverage

Avanos Medical (AVNS) Q4 2024 earnings summary

Avanos Medical (AVNS) reported strong Q4 and full-year 2024 performance, driven by growth in Enteral Feeding and the divestiture of its respiratory health business. Despite a net loss due to a non-cash impairment charge, the company achieved significant increases in adjusted dilu

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 13:11
Source
Quartr
TradingView Direct company coverage

Enterprise value to EBIT forward of Avanos Medical, Inc. – LS:A2JNRG

This article provides financial data for Avanos Medical, Inc. (LS:A2JNRG) focusing on its Enterprise Value to EBIT forward ratio. It highlights the availability of financial figures and market data for the company through TradingView, noting that the market is currently closed.

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 15:39
Source
TradingView
Quartr Direct company coverage

Avanos Medical (AVNS) Q1 2026 earnings summary

Avanos Medical announced its Q1 2026 earnings, reporting net sales of $182.2 million, an 8.8% increase year-over-year, driven by strong growth in Specialty Nutrition Systems. The company also announced a definitive agreement to be acquired by affiliates of American Industrial Par

Tone
Neutral 50/100
Event
Earnings
Published
07 Jul 2026 12:09
Source
Quartr
TradingView Direct company coverage

Enterprise value to revenue forward of Avanos Medical, Inc. – LS:A2JNRG

This article focuses on the enterprise value to revenue forward for Avanos Medical, Inc. (LS:A2JNRG). It appears to be a financial data point from TradingView, indicating a key valuation metric for the company. The content primarily highlights this specific financial metric witho

Tone
Neutral 50/100
Event
Earnings
Published
07 Jul 2026 10:10
Source
TradingView
AD HOC NEWS Direct company coverage

Avanos stock stays tied to medical devices.

Avanos Medical Inc (ISIN US05350V1061) is a Nasdaq-listed medical device company specializing in chronic care, pain management, and digestive health products. The company's business model relies on its portfolio of infection prevention, chronic care, and interventional products,

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 16:10
Source
AD HOC NEWS
Moomoo Direct company coverage

Avanos, American Industrial Get Regulatory Approval for Merger

Avanos and American Industrial have received regulatory approval for their merger. This development marks a significant step forward for the two companies as they proceed with their integration plans.

Tone
Positive 72/100
Event
Deals and strategy
Published
03 Jul 2026 10:10
Source
Moomoo
citybiz Direct company coverage

Avanos Medical, American Industrial Partners Clear Regulatory Hurdle for Merger

Avanos Medical Inc. and American Industrial Partners (AIP) have received all necessary regulatory approvals for AIP's acquisition of Avanos Medical, moving the deal closer to its projected completion later this month. The merger, valued at approximately $2.2 billion, is now subje

Tone
Positive 71/100
Event
Deals and strategy
Published
02 Jul 2026 14:39
Source
citybiz
TradingView Direct company coverage

Avanos receives regulatory approvals, merger expected to close by July 27 pending shareholder vote

Avanos (AVNS) has secured all necessary regulatory approvals for its acquisition by affiliates of American Industrial Partners. The merger is anticipated to finalize by July 27, 2026, contingent on shareholder approval. A special stockholder meeting for Avanos to vote on the merg

Tone
Positive 67/100
Event
Deals and strategy
Published
02 Jul 2026 14:39
Source
TradingView
AD HOC NEWS Direct company coverage

Avanos Medical stock holds its focus on procedure demand

Avanos Medical (AVNS) focuses on procedure demand within its US medtech footprint, with its stock performance tied to hospital and outpatient spending trends. The company, which trades on the NYSE, specializes in products for pain management, digestive health, and respiratory car

Tone
Neutral 50/100
Event
Macro sensitivity
Published
02 Jul 2026 11:39
Source
AD HOC NEWS
Sahm Direct company coverage

Is Avanos Medical (AVNS) Undervalued Or Has Its Strong Run Already Priced In?

Avanos Medical (AVNS) has seen significant stock performance despite recent net losses and declining longer-term returns. The company's current Price-to-Sales (P/S) multiple of 1.6x is below industry and peer averages, suggesting a discount, but is above an estimated fair P/S rat

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 22:40
Source
Sahm
TradingView Direct company coverage

Price to sales forward of Avanos Medical, Inc. – LS:A2JNRG

This article displays the forward price-to-sales ratio for Avanos Medical, Inc. (LS:A2JNRG) on TradingView. It indicates that the market was closed at the time of viewing, with no trades having occurred. The page provides an overview of financial data for the company.

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 08:09
Source
TradingView
AD HOC NEWS Direct company coverage

Avanos Medical with steady outlook, shares tracked against medtech peers

Avanos Medical is focused on single-use medical devices and is situated within a consolidating medtech sector, with its shares tracked against competitors like Medtronic and Boston Scientific. Analysts generally hold a moderate upside view on AVNS shares, focusing on the company'

Tone
Positive 61/100
Event
Guidance
Published
29 Jun 2026 20:41
Source
AD HOC NEWS
www.marketscreener.com Direct company coverage

Avanos Medical, Inc.(NYSE: AVNS) dropped from Russell 2000 Defensive Index

Avanos Medical, Inc. (NYSE: AVNS) has been removed from the Russell 2000 Defensive Index. This news follows several recent updates for the company, including first-quarter earnings results and an announcement of its acquisition by American Industrial Partners for $1.27 billion. A

Tone
Negative 38/100
Event
Deals and strategy
Published
28 Jun 2026 20:52
Source
www.marketscreener.com
TradingView Direct company coverage

Avanos Medical, Inc. Actuals & Estimates (NYSE:AVNS)

This article provides an overview of Avanos Medical, Inc. (NYSE:AVNS) stock's financial performance, including actuals and estimates for income, balance sheet, and cash flow. It details current stock price, historical highs and lows, market capitalization, and upcoming earnings r

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 12:40
Source
TradingView
Finviz Direct company coverage

AVNS - Avanos Medical Inc Latest SEC Filings

This article provides detailed financial data and market performance metrics for Avanos Medical Inc (AVNS), including its stock price, market capitalization, income, sales, and various financial ratios. It also lists key dates, such as IPO and earnings, along with insider and ins

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 21:39
Source
Finviz
TradingView Direct company coverage

Price to earnings forward of Avanos Medical, Inc. – BOATS:AVNS

This article provides the "Price to earnings forward" metric for Avanos Medical, Inc. (AVNS) on the Blue Ocean Alternative Trade System (BOATS) platform. It indicates that the market is closed, with no trades currently available for the stock. The content is primarily a listing o

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 15:10
Source
TradingView
Stock Traders Daily Direct company coverage

Price-Driven Insight from (AVNS) for Rule-Based Strategy

This article provides a price-driven insight into Avanos Medical Inc. (AVNS) for rule-based trading strategies. It highlights neutral near and mid-term readings but a strong long-term positive bias, noting that resistance is being tested. The analysis details institutional tradin

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 22:42
Source
Stock Traders Daily
Business Wire Direct company coverage

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. KSF is scrutinizing the $25.00 per share cash offer to determine if it adequately values the company and if the sales process was fa

Tone
Negative 37/100
Event
Balance sheet
Published
24 Jun 2026 19:09
Source
Business Wire
Market source Direct company coverage

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

Avanos Medical (AVNS) is well-positioned for growth due to its strong product line, particularly in Specialty Nutrition Systems, and strategic acquisitions like Nexus Medical, despite challenges from tariff risks and weaknesses in its Pain Management & Recovery business. The comp

Tone
Positive 60/100
Event
Deals and strategy
Published
24 Jun 2026 13:47
Source
Market source
TradingKey Direct company coverage

Avanos Medical Inc (AVNS) Institutional Confidence

Avanos Medical Inc (AVNS) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. This score reflects a 97.19% institutional shareholding proportion, although this represents a 14.66% decrease quarter-over-quarter. Diamo

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 06:39
Source
TradingKey